What is Inscopix?
Inscopix is at the forefront of developing next-generation therapeutics for challenging brain disorders. The company's core innovation lies in its ability to enable advanced research and predictive preclinical therapeutic development. By providing validated solutions for real-time mapping of neural activity within brain circuits, Inscopix offers objective, quantitative, and in-brain assays. These assays are instrumental in generating unprecedented insights into disease mechanisms and have demonstrated superior accuracy in predicting clinical efficacy compared to traditional animal behavior models when testing a therapeutic candidate's capacity to restore normal brain function. Inscopix's partner and customer discoveries are crucial for decoding the brain, deepening the understanding of disease mechanisms, and facilitating the screening of drugs based on their efficacy.
How much funding has Inscopix raised?
Inscopix has raised a total of $11M across 2 funding rounds:
Series A
$10M
Debt
$1M
Series A (2016): $10M with participation from Playground, AME Cloud Ventures, and Floodgate Fund
Debt (2020): $1M led by PPP
Key Investors in Inscopix
Playground
Playground Global invests in founders harnessing frontier technologies to build transformational businesses with multi-generational impact. Recognizing the promise in early-stage entrepreneurs developing new solutions in artificial intelligence, automation, life sciences, next-gen compute, cybersecurity, aerospace, and beyond, Playground offers world-class expertise across a wide variety of business and technical domains to help companies achieve their potential.
AME Cloud Ventures
AME Cloud Ventures is a venture fund led by Jerry Yang, co-founder of Yahoo!, focusing on seed to later stage companies that build infrastructure and value chains around data. The firm invests in technology-heavy companies that gather or create unique data across various stages of the data stack, from infrastructure to applications. AME Cloud Ventures aims to support true entrepreneurs by providing resources, operational experience, and access to a network of mentors and international partners, particularly in China.
Floodgate Fund
Floodgate Fund is a venture capital firm that specializes in early stage investments in technology companies. The firm aims to support extraordinary founders at the pre-seed and seed stages. Their focus is on identifying and backing innovative companies that are considered pattern breakers in the tech industry. Floodgate positions itself as a trusted partner for entrepreneurs seeking to build impactful businesses.
What's next for Inscopix?
The recent major strategic investment indicates Inscopix is likely in a scaling or late-stage development phase, leveraging this capital to accelerate its therapeutic pipeline and expand its market reach. The company's focus on validated, quantitative assays for neural activity mapping positions it to significantly impact the drug discovery process for neurological conditions. Future endeavors will likely involve further clinical validation of its platform and the advancement of its therapeutic candidates through rigorous testing, aiming to bring novel treatments to patients suffering from difficult-to-treat brain disorders. The strategic nature of the investment suggests potential collaborations or partnerships that could enhance Inscopix's development capabilities and market penetration.
See full Inscopix company page
